Hematocrit

Biomarker2 papers1 finding

Human trial1
Humans1

Interventions

1

Empagliflozin

upin humans1Very low certainty

1 study

Empagliflozin increases hematocrit in humans (1.74 ± 2.08%).
“hematocrit (mean difference = 1.74 ± 2.08%”
Human trialtype 2 diabetes1 month
Metabolic and Lipoprotein Changes in Type 2 Diabetes Patients Treated with Empagliflozin · Biomedicines · 8 Sep 2026

Empagliflozin →

Latest

2

BiomedicinesHuman trial26 Sep

Metabolic and Lipoprotein Changes in Type 2 Diabetes Patients Treated with Empagliflozin

Frontiers in MedicineHumans26 Sep

Mortality prediction in the elderly patients with coronary artery disease and atrial fibrillation: a retrospective machine learning approach